Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | NOD1 | Q9Y239 | 7/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.44 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14160636 | 0.85 | KMT2A (0.55) | KMT2ANOD1POLBMEN1FAAH | |
| SCHEMBL7620286 | 0.84 | CYP1A2 (0.44) | KMT2ANOD1POLBL3MBTL1CYP2C9 | |
| SCHEMBL11092334 | 0.84 | NOD1 (0.66) | KMT2ANOD1POLBMEN1FAAH | |
| SCHEMBL11094036 | 0.84 | NOD1 (0.66) | KMT2ANOD1POLBMEN1FAAH | |
| SCHEMBL11092330 | 0.84 | NOD1 (0.66) | KMT2ANOD1POLBMEN1FAAH | |
| SCHEMBL11088269 | 0.84 | NOD1 (0.66) | KMT2ANOD1POLBMEN1FAAH | |
| SCHEMBL24411036 | 0.81 | KMT2A (0.63) | KMT2ANOD1POLBMEN1FAAH | |
| SCHEMBL24095932 | 0.80 | KMT2A (0.58) | KMT2ANOD1POLBMEN1FAAH | |
| SCHEMBL7614123 | 0.78 | CYP1A2 (0.40) | KMT2ANOD1POLBL3MBTL1CYP2C9 | |
| SCHEMBL23834071 | 0.78 | KMT2A (0.60) | KMT2ANOD1POLBMEN1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0416401-B1 | Use of derivatives of phospholipides as antiviral pharmaceuticals and phospholipides | BOEHRINGER MANNHEIM GMBH (DE) | 1996-10-30 | — | — | EP | disclosed |
| US-5158942-A | PROCESS OF USING PHOSPHOLIPID DERIVATIVES TO INHIBIT MULTIPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS | BOEHRINGER MANNHEIM GMBH (DE) | 1992-10-27 | — | — | US | disclosed |
| EP-0416401-A2 | Use of derivatives of phospholipides as antiviral pharmaceuticals and phospholipides | Roche Diagnostics GmbH (DE) | 1991-03-13 | — | — | EP | disclosed |